Replies to post #125933 on Biotech Values

[DewDiligence]

If MNTA were to ink a comprehensive FoB deal with PFE, do you see any chance of MNTA being able to carve out rights to partner a substitutable Enbrel FoB with another party?

No, I don’t see any chance of that.